Dei Biopharma awaits approvals on first Covid-19 medicine produced in Uganda
DEI Biopharma is expected to produce all of the biologic medicines listed as essential drugs
MATUGGA – Dei Biopharma is awaiting approval of the World Health Organisation (WHO) to out it's Molnupiravir drug, which will be the first such product to treat Covid-19 infection in the world.DEI Biopharma has also laid out the plans for other essential newer products — including Paxlovid, Fluvoxamine, Ritonavir, Nirmatrelvir, and Rilpivirine.The development was announced by DEI Group Managin
beylikdüzü escort,istanbul escort,beylikdüzü escort,ataköy escort,esenyurt escort,avcılar escort,bakırköy escort,esenyurt escort,esenyurt escort,avcılar escort,beylikdüzü escort